Siemens Healthineers stock narrows ultrasound business focus
Published on 11/17/2026 at 11:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSUltrasound strategy shifts toward procedures
- Siemens Healthineers is concentrating ultrasound investment on procedural imaging, intracardiac echocardiography, software and treatment-support solutions.
- New orders for several general-imaging ultrasound systems are being phased out, while installed-base service continues.
- The portfolio change gives investors a sharper view of the company's focus on image-guided therapy.
Siemens Healthineers announced on Tuesday, November 17, 2026, that it is redirecting its ultrasound business toward procedural imaging and image-guided therapy. In a Siemens Healthineers Japan announcement, the company said it would concentrate investment and resources on areas such as intracardiac echocardiography, cardiovascular applications, software, workflow and artificial intelligence.
General imaging portfolio is being reduced
The change affects the general-imaging ultrasound portfolio. Siemens Healthineers said it would generally stop accepting new orders for the ACUSON Sequoia, ACUSON Redwood, ACUSON Juniper and ACUSON P500 systems from mid-October 2026. The company intends to continue developing and selling solutions centered on ACUSON Origin, ACUSON P500 ICE Edition, ACUSON Freestyle, intracardiac echocardiography catheters and related software.
For investors, the move narrows the company's ultrasound exposure toward procedures in which imaging supports treatment rather than diagnosis alone. That focus includes cardiovascular interventions and image-guided workflows, where Siemens Healthineers sees a role for its catheter, software and artificial-intelligence capabilities.
Installed base remains supported
Siemens Healthineers said customers that already use the affected systems will continue to receive maintenance services, software upgrades and probe supplies under their contracts. The company also said contractual terms will govern cases with separate customer arrangements, preserving support for existing users while the portfolio is reshaped.
Siemens Healthineers stock traded at 43.47 euros on Lang & Schwarz at 11:09 CET on Tuesday, November 17, 2026.
Siemens Healthineers stock
- Company: Siemens Healthineers AG
- ISIN: DE000SHL1006
- Lang & Schwarz quote: 43.47 euros at 11:09 CET on November 17, 2026
European equities can be followed through the DAX.
